Sponsored Links

 

Displaying sitagliptin PowerPoint Presentations



Sitagliptin/Metformin Clinical Slide Kit PPT

Presentation Summary : Title: Sitagliptin/Metformin Clinical Slide Kit Author: jim.bergstrom Last modified by: user Created Date: 11/14/2006 11:19:00 PM Document presentation format

Source : http://josephinecarlosraboca.weebly.com/uploads/5/0/2/2/5022425/januvia-janumet_june_24_2010.ppt_final.ppt

Incretin Based Therapy of Type 2 Diabetes Mellitus PPT

Presentation Summary : Dipeptidyl Peptidase-IV Antagonists Sitagliptin and Vildagliptin Sitagliptin and vildagliptin are the first agents in this class to have received FDA approval.

Source : http://www.bibalex.org/diabetessupercourse/DiabetesPPTLectures/Copy%20of%20Incretin%20Based%20Therapy%20of%20Type%202%20Diabetes%20Mellitus_1.ppt

American Diabetes Association - DiabetesPro - Home - American ... PPT

Presentation Summary : standards of medical care in diabetes—2012

Source : http://professional.diabetes.org/SlideLibrary/media/4839/ADA%20Standards%20of%20Medical%20Care%202012%20FINAL.ppt

No Slide Title PPT

Presentation Summary : Sitagliptin Renal Insufficiency Study Design: Open label, single dose Subjects: 24 patients with renal insufficiency (6 mild, 6 moderate, 6 severe ...

Source : http://www.fda.gov/ohrms/dockets/ac/08/slides/2008-4351s2-01-GuestSpeakers-corepresentation.ppt

No Slide Title PPT

Presentation Summary : Sitagliptin is a potent and selective DPP-4 inhibitor, very well tolerated in pre-clinical toxicity studies and in human clinical trials. In patients with type 2 ...

Source : http://www.nedmdg.org/docs/2010/2010summer_symposium/DPP4.ppt

PowerPoint Presentation PPT

Presentation Summary : ... a DPP-IV inhibitor (sitagliptin). However, this agent has limited glucose lowering efficacy (about half the effect of established therapies) ...

Source : http://www.fda.gov/ohrms/dockets/ac/08/slides/2008-4368s1-06-Guest-Nissen.ppt

Slide 1 PPT

Presentation Summary : ... (Merck & co. - Sitagliptin), the first in class compound was launched in Oct’06; JanuMet (Sitagliptin + Metformin) launched in Apr 07.

Source : http://www.glenmarkpharma.com/Common/pdf/Glenmark_Analyst_Ppt.ppt

053 Slides - Josephine Carlos-Raboca M.D. PPT

Presentation Summary : June 5–9, 2009. Initial Fixed-Dose Combination Therapy With JANUMET™† (sitagliptin/metformin FDC) vs Metformin Monotherapy 079 Study ...

Source : http://josephinecarlosraboca.weebly.com/uploads/5/0/2/2/5022425/pn079_janumet_metformin_ml.ppt

Insulin Management PPT

Presentation Summary : ... Basal Insulin in Type 2 Diabetes Some oral meds may be continued -metformin, maybe TZD, maybe SU, maybe gliptin (sitagliptin) Glargine (Lantus) or Detemir ...

Source : http://www.diabetesnd.org/image/cache/Diabetes__Medications_Dr._Eric_Johnson_Jan_19_2012.ppt

Differentiating Among Incretin Agents for Type 2 Diabetes ... PPT

Presentation Summary : ... Concern About Acute Pancreatitis Sitagliptin and Exenatide Associated With Increased Risk for Hospitalization for Acute Pancreatitis Incretin-based Therapies: ...

Source : http://img.medscape.com/images/779/858/779858_slides.ppt

PowerPoint Presentation PPT

Presentation Summary : ... Sitagliptin (DPP-IV inhibitor) Liraglutide (GLP-1 receptor agonist) . 2005 2006 2007 2010 2008 2009 Saxagliptin (DPP-IV inhibitor) Newer Classes of ...

Source : http://www.lafmeded.org/Diabetes-Oates-2012.ppt

Slide 1 PPT

Presentation Summary : * Effect of Sitagliptin + Metformin on A1C in Patients With Type 2 Diabetes In this 24-week, randomized, placebo-controlled, parallel-group study, ...

Source : http://www.wcapn.org/doc/DPP4_presentation.ppt

Perioperative Care For the General Surgical Patient PPT

Presentation Summary : ... Sulfunylureas-glipizide, glyburide or glimeperide Insulin secretagogues, non glucose dependent DPP-4 Inhibitors Sitagliptin (Januvia) ...

Source : http://www.swmedicalcenter.org/documents/CME/GlycemicControl/Lester%20Sherington%20Kyper%20Perioperative.ppt

PowerPoint Presentation PPT

Presentation Summary : Sitagliptin reduces HGO through suppression of glucagon from alpha cells. Metformin decreases HGO by targeting the liver to decrease gluconeogenesis and glycogenolysis.

Source : http://sciotocountymedicalsociety.org/documents/MMF4CoreDefectsofType2Diabetes.ppt

THERAPEUTIC APPROACHES TO THE B-CELL DYSFUNCTION OF NIDDM PPT

Presentation Summary : Jack L. Leahy, MD Endocrinology, Diabetes and Metabolism University of Vermont Initial Combination With Sitagliptin Plus Metformin Study: Design Week –2 Day 1 ...

Source : http://www.acponline.org/about_acp/chapters/ak/meet09/leahy1-09.ppt

Diabetes Case Studies - University of North Dakota PPT

Presentation Summary : Gliptin (sitagliptin or saxagliptin) Both have low risk of significant hypoglycemia, can be renally dosed, easy to use, few significant drug interactions. Brosseau JD.

Source : http://www.med.und.edu/familymedicine/slidedecks/documents/DiabetesCaseStudiesPA5-25-11.pptx

Oral Hypoglycemic Update - Lafayette Medical Education Foundation PPT

Presentation Summary : Class DPP-4 inhibitors (incretin enhancers) Compound Sitagliptin (Januvia®) Vildagliptin (available in Europe) Saxagliptin (Onglza®) Linagliptin ...

Source : http://www.lafmeded.org/PP-Schwartz.ppt

New Diabetes Medications - Baylor College of Medicine PPT

Presentation Summary : ... Novartis pill DPP-IV inhibitor sitagliptin (Januvia) Merck pill DPP-IV inhibitor Exenatide (Byetta): GLP-1 mimic Approved 6/2004 Synthetic version of ...

Source : http://www.bcm.edu/education/programs/medpeds/powerpoints/NewDiabetesMedications2.pps

New Diabetes Medications - Baylor College of Medicine PPT

Presentation Summary : ... (DPP-IV inhibitor) (Vildagliptin) Galvus & (Sitagliptin) Januvia Inhibits the destruction of GLP-1 (DPP-IV inhibitor; dipeptidyl peptidase IV inhibitor) ...

Source : http://www.bcm.edu/education/programs/medpeds/powerpoints/NewDiabetesMeds.pps

TMA DoD Pharmacoeconomic Center Fort Sam Houston, TX PPT

Presentation Summary : When added to metformin, sitagliptin and linagliptin have shown a decrease in weight ranging from 0.4-1.4kg. Overall Clinical Effectiveness Conclusion.

Source : http://www.pec.ha.osd.mil/files/PECwebcast_Dec12.pptx

PowerPoint Presentation PPT

Presentation Summary : Merck Canada Inc. benefits from the sale of the products that will be discussed in this program: Sitagliptin (Januvia®), Combination Sitagliptin/Metformin (Janumet ...

Source : http://www.optimalplus.ca/en/documents_cas2/DisclosureSlides.pptx

De progressie van de ziekte afremmen door de behandeling. PPT

Presentation Summary : ... (Galvus, Novartis), SYR 322 (Takeda, fase 3 studies) 52-week Sitagliptin vs Sulfonylureaa Add-on Therapy to Metformin Study Sitagliptin Once Daily Showed ...

Source : http://www.imelda.be/professionals/symposia_vorming/Ipodium/Ipodium07/9_antidiabetica.ppt

PowerPoint bemutató - NEPHROLOGIA PPT

Presentation Summary : Sitagliptin 100 mg once daily with metformin induced a significant decrease in body weight that was maintained through week 52 of the study (–1.5 kg), ...

Source : http://www.nephrologia.com/eloadasok/2013-05-31/301.ppt

Slide 1 PPT

Presentation Summary : ... insulin release Multiple targets may lead to unwanted effects on immune function Possible safety issues Vildagliptin, sitagliptin, ...

Source : http://sciotocountymedicalsociety.org/documents/Current.Therapy.GLP-1.Sherraden.ppt

AC2993 (Synthetic Exendin-4) A Potential New Anti-Diabetic Agent PPT

Presentation Summary : Initial Combination Therapy With Sitagliptin Plus Metformin Study: A1C Results Through 104 Wks (2 years): 1. Goldstein BJ et al. Diabetes Care. 2007;30(8) ...

Source : http://professional.diabetes.org/UserFiles/Diabetes%20Medication%20Treatment%20in%20the%2021st%20Century.ppt

Sponsored Links
If you find powerpoint presentation a copyright It is important to understand and respect the copyright rules of the author.
Please do not download if you find presentation copyright.
If you find a presentation that is using one of your presentation without permission, contact us immidiately at

© XPowerPoint.com